97155 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Anti-CXCL13 antibodies and methods of using the same
#602Chimeric molecule involving oligomerized FasL extracellular domain
#603DIAGNOSIS AND TREATMENT OF TRAUMATIC BRAIN INJURY
#604ANTI MIF ANTIBODIES
#605NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS
#606THERAPEUTIC ANTIBODIES AND USES THEREOF
#607Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor
#608Sequence asymmetric modified IgG4 bispecific antibodies
#609Polynucleotides encoding ZCYTOR17 ligand antibodies
#610METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#611Antibodies that inhibit TSLP activity
#612Dual Variable Domain Immunoglobulin and Uses Thereof
#613OSTEOPONTIN ISOFORM A INHIBITORS AND METHODS OF USE
#614Anti-Bv8 antibodies and uses thereof
#615Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders
#616Myonectin (CTRP15), compositions comprising same, and methods of use
#617SDF-1 Binding Nucleic Acids and the Use Thereof
#618Methods for the treatment or prevention of systemic sclerosis
#619Vascular endothelial growth factor 2
#620MONOCLONAL ANTIBODY AGAINST INTERFERON-GAMMA (IFN-GAMMA) INDUCING FACTOR (IFIG, IL-18)
#621Method for treating psoriasis
#622Biomarkers for TSLP treatment
#623Proteins specific for BAFF and B7RP1
#624Methods of obtaining a specific binding member that binds eotaxin
#625Characterization of CHO-MIF gene and protein, and use thereof
#626Notch agonists for the treatment of cancer
#627Anti-human CXCR4 antibodies and methods of making same
#628USE OF ANTI-EOTAXIN ANTIBODIES FOR TREATING INFLAMMATORY BOWEL DISEASE
#629USE OF ANTI-EOTAXIN ANTIBODIES FOR TREATING INFLAMMATORY BOWEL DISEASE
#630Pan-ELR+ CXC Chemokine Antibodies
#631Ion concentration-dependent binding molecule library
#632BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS
#633OxMIF as a diagnostic marker
#634Method for treating a neurological disorder associated with hypoxia using a small moleucule MIF inhibitor
#635Method and reagent for diagnosis and/or evaluation of progression of graft-versus-host disease
#636Chimeric and humanized anti-histone antibodies
#637Methods of treating pancreatitis
#638STABLE FORMULATIONS OF ANTIBODIES TO TSLP
#639Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
#640Human IL-23 antigen binding proteins
#641Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#642Methods for preparing interferon alpha antibodies
#643Compositions for regulating iron homeostasis and methods of using same
#644Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#645Antibodies against monocyte chemotactic proteins
#646Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (C-C motif) Ligand 2 (CCL2)
#647Inhibition of bone resorption with RANKL binding peptides
#648Focused radiation for augmenting immune-based therapies against neoplasms
#649Chemokine binding polypeptides for treating autoimmunity and inflammation
#650Humanized anti-EMAP II antibody and use thereof
#651ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
#652ENGINEERED ANTI-TSLP ANTIBODY
#653ENGINEERED ANTI-TSLP ANTIBODY
#654IP-10 antibody dosage escalation regimens
#655Antibodies that are cross-reactive for macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (D-DT)
#656Method for treating sarcopenia using antagonist antibodies against GDF-8
#657Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function
#658Treatment of chronic pelvic pain syndrome
#659HUMANIZED ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS
#660Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#661Methods for treating melanoma
#662Multivalent and Monovalent Multispecific Complexes and Their Uses
#663Method of treating hypertension disorder and a pharmaceutical agent
#664Antibodies against the S100P protein for the treatment and diagnosis of cancer
#665Nucleic acids encoding neutralizing anti-CCL20 antibodies
#666Activatable binding polypeptides and methods of identification and use thereof
#667HMGB1 specific monoclonal antibodies
#668Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury
#669Method for treating malaria
#670Stem cell factor inhibitor
#671ORGANIC COMPOUNDS
#672Antibodies of the class IGG4
#673ANTI-LIGHT ANTIBODY THERAPY FOR INFLAMMATORY BOWEL DISEASE
#674Method of treating a pathological syndrome and a pharmaceutical agent
#675Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)
#676Method of treating a pathological syndrome and a pharmaceutical agent
#677Antibodies that bind factor P
#678METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#679Covalently dimerized bivalent binding agents
#680Antagonistic human light-specific human monoclonal antibodies
#681Antibodies That Inhibit TSLP Activity
#682Anti-IP-10 Antibodies and Uses Thereof
#683Removal of high molecular weight aggregates using hydroxyapatite chromatography
#684Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms
#685ANTIBODIES FOR THE TREATMENT OF HIV
#686Method of treating atopic dermatitis with antibody to zcytor17 ligand
#687MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS
#688Antibody recognizing human leukemia inhibitory factor (LIF)
#689Reducer of immunosuppression by tumor cell and antitumor agent using the same
#690Antikine antibodies that bind to multiple CC chemokines
#691Method of supplementing culture media to prevent undesirable amino acid substitutions
#692Method for treating psoriasis
#693METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#694Extracellular IFI16 as therapeutic agents
#695BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS
#696HMG1 antibody for treating inflammatory conditions
#697Identifying affinity-matured human antibodies
#698Treatment of neuroinflammatory conditions using antibodies directed against MCAM
#699Pharmaceutical compositions and methods of treatment
#700Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
#701Engineered anti-TSLP antibody
#702Method for treating pathologies associated with hypoxia using MIF inhibitors
#703Engineered anti-TSLP antibody
#704Human IL-23 antigen binding proteins
#705Dual Variable Domain Immunoglobulin and Uses Thereof
#706Stem cell factor inhibitor
#707Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#708NOVEL USES
#709Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
#710Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
#711Compositions and methods for diagnosis and treatment of tumors
#712ANTI-TGF-BETA INDUCTION OF BONE CELL FUNCTION AND BONE GROWTH
#713METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#714Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#715Methods of obtaining a specific binding member that binds eotaxin
#716Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders
#717ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION
#718Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
#719ANTIBODIES TO M-CSF
#720Activatable binding polypeptides and methods of identification and use thereof
#721Activatable binding polypeptides and methods of identification and use thereof
#722VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF
#723Activatable binding polypeptides and methods of identification and use thereof
#724IP-10 antibodies and their uses
#725METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#726Engineered anti-TSLP antibody
#727Compositions and methods for treating inflammatory disorders
#728VASCULAR ENDOTHELIAL GROWTH FACTOR 2
#729Cytokine zalpha11 ligand
#730Anti-RANTES antibodies
#731Antigen binding proteins capable of binding thymic stromal lymphopoietin
#732SUPPRESSANT FOR ATHEROSCLEROSIS
#733Interleukin-1 Alpha Antibodies and Methods of Use
#734Anti-IL-TIF antibodies and methods of use
#735INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#736Neutralizing anti-CCL20 antibodies
#737Compositions and methods for the diagnosis and treatment of immune disorders
#738DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#739Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
#740Anti-IL-6 antibodies for the treatment of arthritis
#741Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
#742Ang-2 Binding Complexes and Uses Thereof
#743Therapeutic Agent
#744Stable and soluble antibodies
#745Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
#746Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
#747DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES
#748Antagonistic human LIGHT-specific human monoclonal antibodies
#749AGENT FOR PROMOTING HEPATIC CELL REPLICATION AND AGENT FOR IMPROVING INSULIN RESISTANCE
#750Methods for treating melanoma
#751ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION
#752Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#753B LYMPHOCYTE STIMULATOR ASSAYS
#754MIF antagonists
#755Methods of treatment using antibodies to Neutrokine-alpha
#756Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins
#757Methods for the treatment or prevention of systemic sclerosis
#758INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#759Interleukin-1 Alpha Antibodies and Methods of Use
#760Thymic Stromal Lymphopoietin (TSLP) and OX40 Ligand in Cancer
#761Polynucleotides encoding antagonist antibodies against GDF-8
#762Degraded TPO agonist antibody
#763Interleukin-1 alpha antibodies and methods of use
#764Interleukin-1α antibodies and methods of use
#765Interleukin-1 alpha antibodies and methods of use
#766Antibodies that inhibit TSLP activity
#767Anti-BV8 antibodies and uses thereof
#768Method for treating muscular dystrophy using antagonist antibodies against GDF-8
#769Method for Producing Proteins
#770Monoclonal antibody and use thereof
#771DETECTION OF IFI16 IN BODY FLUIDS
#772Interferon alpha antibodies and their uses
#773Treatment of chronic pelvic pain syndrome
#774Methods for identifying and isolating cells expressing a polypeptide
#775METHODS FOR MONOCLONAL ANTIBODY PRODUCTION
#776Immunoassay method for human CXCL1 protein
#777METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#778High affinity antibodies against HMGB1 and methods of use thereof
#779MODULATING ANGIOGENESIS
#780Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#781METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#782Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
#783Antibody-Guided Fragment Growth
#784Methods of treating TSLP-related inflammatory disorders
#785METHODS OF TREATING INFLAMMATION
#786Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)
#787GENERATION OF ANTIBODIES TO AN EPITOPE OF INTEREST
#788Humanized antibodies against monocyte chemotactic proteins
#789Method of treating amykloidosis comprising administering an anti-HMGB-1 antibody
#790Compounds
#791Vascular endothelial growth factor 2
#792Antibodies That Specifically Bind to Chemokine Beta-4
#793SDF-1 binding nucleic acids and the use thereof
#794Monoclonal antibodies against HMGB1
#795Murine zcytor17 ligand polynucleotides
#796Antibody variants
#797TGF-Beta Antagonist Multi-Target Binding Proteins
#798Modified anti-heparin/PF4 complex antibody and HIT antibody standard
#799OSTEOPONTIN ANTIBODIES
#800NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#801Heparin-Binding Growth Factor (HBGF) Polypeptides
#802ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#803Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#804B LYMPHOCYTE STIMULATOR ASSAYS
#805ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#806Anti-HMGA1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of HMGA1
#807CCL20-SPECIFIC ANTIBODIES FOR CANCER THERAPY
#808Method for modulating appetite
#809METHOD OF MODULATING FIBROBLAST ACCUMULATION OR COLLAGEN DEPOSITION
#810ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#811ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#812Antibodies for the treatment of HIV
#813Method for administering homeopathically potentiated antibodies against mediator of inflammation
#814ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#815ANTI-CHEMOKINE AND ASSOCIATED RECEPTORS ANTIBODIES FOR INHIBITION OF GROWTH OF NEOPLASMS
#816Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
#817Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#818Antikine antibodies that bind to multiple CC chemokines
#819Future cardiac event biomarkers CCL3, CCL5 and CCL18
#820NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#821KIT FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE
#822METHODS OF TREATMENT USING ANTI-MIF ANTIBODIES
#823Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof
#824ANTI-BRAK (CXCL14) HUMAN MONOCLONAL ANTIBODY AND USE THEREOF
#825Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#826MCAM modulation and uses thereof
#827Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#828Anti-IP-10 antibodies and methods of use thereof
#829METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA
#830DNA encoding a soluble fragment of TRAIL polypeptide
#831Compositions and methods for diagnosis and treatment of tumors
#832THERAPEUTIC AND PROPHYLACTIC METHODS FOR NEUROMUSCULAR DISORDERS
#833Human anti-IP-10 antibodies uses thereof
#834EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#835HMGB1 PROTEIN INHIBITORS AND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES
#836Cytokine zalpha11 ligand antibodies
#837CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#838REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#839Therapeutic Agent
#840ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES
#841ANTIBODIES THAT INHIBIT TSLP ACTIVITY
#842Compositions and methods for diagnosing and treating prostate cancer
#843Methods of diagnosing and prognosing hodgkin's lymphoma
#844NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#845Anti MIF antibodies
#846Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
#847ANTI-MCP-1 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#848Nucleic acid molecules encoding antibodies to M-CSF
#849THE FUNCTIONAL EPITOPE OF OSTEOPONTIN, THE ANTI-OSTEOPONTIN MONOCLONAL ANTIBODY AND USE THEREOF
#850Method of treating disorders of the cardiovascular system and a pharmaceutical agent
#851Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis B
#852Cytokine zalpha11 ligand antibodies
#853Method of treating a pathological syndrome and a pharmaceutical agent
#854THERAPEUTIC AGENT FOR INTERSTITIAL PULMONARY DISEASE COMPRISING ANTI-HMGB-1 ANTIBODY
#855METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#856Use of SDF-1 to improve ischemic myocardial function
#857Method of treating a disorder or condition of viral etiology
#858NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#859Method for separation of immunoglobulin monomers
#860Method for determining MIF content
#861METHOD FOR DETECTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE
#862Agent for Suppressing Rejection in Organ Transplantation Comprising Anti-HMGB-1 Antibody
#863HMG1 antibody for treating inflammatory conditions
#864HMGB1 PROTEIN INHIBITORS AND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES
#865Engineered anti-TSLP antibody
#866Method for administering homeopathically potentized antibody
#867Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins
#868USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER
#869Monoclonal antibodies against stromal derived factor-1 (SDF-1)
#870OSTEOPONTIN FUNCTIONAL EPITOPES, MONOCLONAL ANTIBODIES AGAINST THE EPITOPES AND USES THEREOF
#871MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF
#872EPHA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#873METHODS AND COMPOSITIONS FOR PROLONGING ELIMINATION HALF-TIMES OF BIOACTIVE COMPOUNDS
#874Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)
#875Monoclonal antibody and use thereof
#876Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#877Nucleic acids encoding CCL27
#878Molecular Antigen Arrays
#879Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders
#880Antibodies to CXCL13
#881Anti-IL-TIF antibodies and methods of making
#882IP-10 antibodies and their uses
#883Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#884CCR2 ANTAGONISTS FOR TREATMENT OF FIBROSIS
#885Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#886High affinity antibodies against HMGB1 and methods of use thereof
#887Dual variable domain immunoglobulin and uses thereof
#888ANTIBODY VARIANTS
#889Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
#890METHODS FOR DIAGNOSING AND TREATING CANCER
#891Antagonistic human LIGHT-specific human monoclonal antibodies
#892Antibodies to IP-10 for treating bone diseases with bone destruction
#893LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS
#894Interferon alpha antibodies and their uses
#895DEGRADED AGONIST ANTIBODY
#896ACTIVATABLE BINDING POLYPEPTIDES AND METHODS OF IDENTIFICATION AND USE THEREOF
#897Compositions and methods for the diagnosis and treatment of immune disorders
#898Interleukin-1α antibodies
#899AVIAN-DERIVED ANTIBODY CAPABLE OF BINDING SPECIFICALLY TO HUMAN HMGB1, IMMUNOLOGICAL DETERMINATION METHOD FOR HUMAN HMGB1, AND IMMUNOLOGICAL DETERMINATION REAGENT FOR HUMAN HMGB1
#900CCR2 ANTAGONISTS FOR CHRONIC ORGAN TRANSPLANTATION REJECTION